美国65岁及以上人群肺炎球菌疫苗接种模式:回顾性数据库分析
本研究基于美国索赔数据库,分析2013至2017年满65岁且持续参加Medicare Advantage计划人群的肺炎球菌疫苗接种模式、两剂疫苗间隔及系列完成相关因素。共纳入224,132名成人,仅16.8%完成系列接种,多数未接种或仅接种一剂;有医生办公室、门诊或药房就诊及接种流感疫苗者更可能完成系列。
要点
- 仅16.8%的65岁以上成人完成PCV13-PPV23或PPV23-PCV13系列接种。
- 49%未接种任何肺炎球菌疫苗,34.3%仅接种一剂。
- 有就诊或接种流感疫苗者系列完成率显著更高(P<0.001)。
核心结论
- 尽管2014年已有推荐,美国65岁及以上人群肺炎球菌疫苗系列完成率仍较低,需改进系列完成以降低疾病负担。
研究设计与样本
- 回顾性索赔数据库分析,使用Clinformatics DataMart™数据库,纳入2013年1月1日至2017年6月30日满65岁且持续参保≥15个月的Medicare Advantage成人。
主要发现
- 共纳入224,132名成人,49%未接种肺炎球菌疫苗,34.3%仅接种一剂,16.8%完成系列接种。
- 仅接种一剂者中,11.6%接种PPV23,22.7%接种PCV13。
- PCV-PPV23系列两剂平均间隔420.8天(约14个月),PPV23-PCV13系列平均间隔595.5天(约20个月)。
- 有至少一次医生办公室、门诊或药房就诊者,以及满65岁后第一年接种流感疫苗者,完成系列接种的可能性显著更高(均P<0.001)。
临床怎么用
- 应关注65岁及以上成人肺炎球菌疫苗系列完成情况,尤其利用就诊和流感疫苗接种机会促进后续剂次接种。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This study investigated the patterns of pneumococcal disease vaccination, the time between two different pneumococcal vaccine doses and factors associated with series completion. METHODS: A retrospective claims database analysis was conducted using the Clinformatics DataMart™ database. Adults who turned 65 years between January 1st, 2013 to June 30th, 2017 and were continuously enrolled (≥15 months) in the Medicare Advantage plans to June 30th, 2017 were included in this study. Pneumococcal vaccination patterns included: PCV13-PPV23, PPV23-PCV13, or receiving PPV23 or PCV13 only. Pneumococcal vaccination series completion was defined as receiving PCV13-PPV23 or PPV23-PCV13 from 65 years old to June 30th, 2017 while non-completion was defined as receiving only PCV13 or only PPV23 from 65 years old to June 30th, 2017. A multivariable logistic regression model was used to identify factors associated with pneumococcal vaccination series completion. RESULTS: A total of 224,132 adults were included in this study. Most received no pneumococcal vaccination (49%), while 34.3% received only one vaccine. Series completion occurred in 16.8% of adults. Some adults received only one vaccination: 11.6% received PPV23 and 22.7% received PCV13. The mean time between vaccinations was 420.8 days (approximately 14 months) for the PCV-PPV23 series, and 595.5 days (approximately 20 months) for the PPV23-PCV13 series. Adults were significantly more likely to complete pneumococcal vaccination series if they had at least one doctor's office, outpatient visit, or pharmacy visit versus no visits, or received an influenza vaccination in the first year after turning 65 years than those who did not (All: P < 0.001). CONCLUSION: Despite the 2014 recommendation, percentages of pneumococcal vaccination series completion were found to be low, aligning with recent literature. This highlights the need to improve series completion, given the increased risk and associated economic burden of pneumococcal disease in adults aged ≥65 years.
引用
- Yang X, Zhang D, Ou W, et al. Pneumococcal vaccination patterns among persons aged 65 years or older in the United States: A retrospective database analysis. Vaccine. 2018. PMID: 30391053. doi:10.1016/j.vaccine.2018.10.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。